NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancer

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancer ; volume:149 ; number:15 ; day:7 ; month:8 ; year:2023 ; pages:14035-14043 ; date:11.2023
Journal of cancer research and clinical oncology ; 149, Heft 15 (7.8.2023), 14035-14043, 11.2023

Creator
Koehler, Viktoria Florentine
Achterfeld, Josefine
Sandner, Natalie
Koch, Christine
Wiegmann, Jonas Paul
Ivanyi, Philipp
Käsmann, Lukas
Pusch, Renate
Wolf, Dominik
Chirica, Mihaela
Knösel, Thomas
Demes, Melanie-Christin
Kumbrink, Joerg
Vogl, Thomas J.
Meyer, Gesine
Spitzweg, Christine
Bojunga, Joerg
Kroiss, Matthias
Contributor
SpringerLink (Online service)

DOI
10.1007/s00432-023-05134-x
URN
urn:nbn:de:101:1-2024011008152673704618
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:28 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Koehler, Viktoria Florentine
  • Achterfeld, Josefine
  • Sandner, Natalie
  • Koch, Christine
  • Wiegmann, Jonas Paul
  • Ivanyi, Philipp
  • Käsmann, Lukas
  • Pusch, Renate
  • Wolf, Dominik
  • Chirica, Mihaela
  • Knösel, Thomas
  • Demes, Melanie-Christin
  • Kumbrink, Joerg
  • Vogl, Thomas J.
  • Meyer, Gesine
  • Spitzweg, Christine
  • Bojunga, Joerg
  • Kroiss, Matthias
  • SpringerLink (Online service)

Other Objects (12)

Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status

Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status

Ultrasound-guided implantation of radioactive 125I seed in radioiodine refractory differentiated thyroid carcinoma

Ultrasound-guided implantation of radioactive 125I seed in radioiodine refractory differentiated thyroid carcinoma

Radio-iodine refractory thyroid cancer patients: a tailored follow-up based on clinicopathological features

Radio-iodine refractory thyroid cancer patients: a tailored follow-up based on clinicopathological features

Successful pregnancy without disease progression of radioiodine refractory papillary thyroid carcinoma: a case report

Successful pregnancy without disease progression of radioiodine refractory papillary thyroid carcinoma: a case report

Molecular evidence reveals thyrotropin intervention enhances the risk of developing radioiodine-refractory differentiated thyroid carcinoma

Molecular evidence reveals thyrotropin intervention enhances the risk of developing radioiodine-refractory differentiated thyroid carcinoma

Potential application of [18F]AlF-PSMA-11 PET/CT in radioiodine refractory thyroid carcinoma

Potential application of [18F]AlF-PSMA-11 PET/CT in radioiodine refractory thyroid carcinoma

Metabolomic screening of radioiodine refractory thyroid cancer patients and the underlying chemical mechanism of iodine resistance

Metabolomic screening of radioiodine refractory thyroid cancer patients and the underlying chemical mechanism of iodine resistance

Scoring system and a simple nomogram for predicting radioiodine refractory differentiated thyroid cancer: a retrospective study

Scoring system and a simple nomogram for predicting radioiodine refractory differentiated thyroid cancer: a retrospective study

Tenosynovial Giant Cell Tumor of Foot in a Patient with Radioiodine-Refractory Thyroid Cancer: Imaging Findings on FDG-PET/CT, MRI, and Radioiodine Scan

Tenosynovial Giant Cell Tumor of Foot in a Patient with Radioiodine-Refractory Thyroid Cancer: Imaging Findings on FDG-PET/CT, MRI, and Radioiodine Scan

Progressive Unilateral Proptosis and (18F) FDG-Avid Lesions Connoting Aggressive Disease in Radioiodine-Refractory Differentiated Thyroid Carcinoma

Progressive Unilateral Proptosis and (18F) FDG-Avid Lesions Connoting Aggressive Disease in Radioiodine-Refractory Differentiated Thyroid Carcinoma

TERT promoter mutations contribute to adverse clinical outcomes and poor prognosis in radioiodine refractory differentiated thyroid cancer

TERT promoter mutations contribute to adverse clinical outcomes and poor prognosis in radioiodine refractory differentiated thyroid cancer

Exposure–response analysis and simulation of lenvatinib safety and efficacy in patients with radioiodine-refractory differentiated thyroid cancer

Exposure–response analysis and simulation of lenvatinib safety and efficacy in patients with radioiodine-refractory differentiated thyroid cancer

Related objects